Cannabidiol monotherapy for treatment-resistant schizophrenia (2006)
- Authors:
- USP affiliated authors: ZUARDI, ANTONIO WALDO - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; MORAIS, SILVIO LUIZ - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP
- Unidade: FMRP
- DOI: 10.1177/0269881106060967
- Assunto: ESQUIZOFRENIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Phychopharmacology
- ISSN: 0269-8811
- Volume/Número/Paginação/Ano: v. 20, n. 5, p. 683-686, 2006
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ZUARDI, Antonio Waldo et al. Cannabidiol monotherapy for treatment-resistant schizophrenia. Journal of Phychopharmacology, v. 20, n. 5, p. 683-686, 2006Tradução . . Disponível em: https://doi.org/10.1177/0269881106060967. Acesso em: 14 fev. 2026. -
APA
Zuardi, A. W., Hallak, J. E. C., Dursun, S. M., Morais, S. L., Sanches, R. F., Musty, R. E., & Crippa, J. A. de S. (2006). Cannabidiol monotherapy for treatment-resistant schizophrenia. Journal of Phychopharmacology, 20( 5), 683-686. doi:10.1177/0269881106060967 -
NLM
Zuardi AW, Hallak JEC, Dursun SM, Morais SL, Sanches RF, Musty RE, Crippa JA de S. Cannabidiol monotherapy for treatment-resistant schizophrenia [Internet]. Journal of Phychopharmacology. 2006 ; 20( 5): 683-686.[citado 2026 fev. 14 ] Available from: https://doi.org/10.1177/0269881106060967 -
Vancouver
Zuardi AW, Hallak JEC, Dursun SM, Morais SL, Sanches RF, Musty RE, Crippa JA de S. Cannabidiol monotherapy for treatment-resistant schizophrenia [Internet]. Journal of Phychopharmacology. 2006 ; 20( 5): 683-686.[citado 2026 fev. 14 ] Available from: https://doi.org/10.1177/0269881106060967 - Electroconvulsive therapy for coexistent schizophrenia and obsessive-compulsive disorder
- Clozapine treatment of patients with refractory schizophrenia, concurrent dengue infection and hematological abnormalities: three case reports
- A false case of clozapine-resistant schizophrenia
- Cannabidiol and neuroprotection: evidence from preclinical studies
- Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13
- Marijuana, feijoada and the debate on drug legalization
- Cannabidiol for the treatment of psychosis in Parkinson's disease
- Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol
- Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
Informações sobre o DOI: 10.1177/0269881106060967 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
